Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that it will present at the 17th Annual BIO CEO and Investor Conference on Tuesday, February 10, 2015.
Help employers find you! Check out all the jobs and post your resume.
